Additionally, some LRRK2 PD patients display PSP-like symptoms together with hyperphosphorylated tau pathology found on post-mortem immunohistochemistry (IHC) analysis [6, 79, 99]. This evidence concerns the gene LRRK2 and Parkinson disease.